NorthStar Healthcare Income, Inc.
NHHSReal Estate · Real Estate Investment Trusts · MD · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $49.8M | $47.6M | $44.3M | $106.0M | $118.1M | $130.1M |
| Operating income | — | — | — | — | — | — |
| Net income | $97.6M | −$160.2M | −$54.5M | $26.8M | −$264.2M | −$18.6M |
| Total assets | $1.13B | $1.06B | $1.24B | $1.41B | $1.92B | $2.14B |
| Total liabilities | $900.9M | $927.7M | $936.8M | $966.1M | $1.51B | $1.47B |
| Equity | $231.1M | $132.9M | $299.0M | $444.5M | $409.6M | $662.4M |
| EPS (diluted) | $0.53 | $-0.83 | $-0.28 | $0.13 | $-1.38 | $-0.41 |
| Shares out. | 185.7M | 195.4M | 193.6M | 190.8M | 189.1M | 189.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- —
- Net margin
- 195.8%
- Return on equity
- 42.2%
- Return on assets
- 8.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 79.7%
- Debt / equity
- 3.90×
- Book value / share
- $1.24
- Revenue growth (YoY)
- 4.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Accruals / assets
- 6.5%moderate
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- High leverage (liabilities > 70% of assets)
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Comrit Investments 1, LpPassive (13G)Feb 11, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJun 9, 2025
- Shareholder voteJun 4, 2025
- Other material eventMay 23, 2025
- Regulation FD disclosureMar 18, 2025
- Entered a material agreement · Director / officer change · Other material eventJan 30, 2025
- Other material eventNov 26, 2024
- Regulation FD disclosureNov 8, 2024
- Regulation FD disclosure · Other material eventOct 17, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.